The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...

AbbVie ABBV announced strong fourth-quarter 2024 results last week, beating estimates for both earnings and sales. While earnings of $2.16 per share declined around 22% year over year, sales rose ...

WASHINGTON — The bromance between Presidents Donald Trump and Vladimir Putin has noticeably fizzled in the new term, though Trump has yet to reveal the extent to which he’ll pressure Russia to ...

Humira's reign has come to an end, but it's not the end for AbbVie. AbbVie’s Humira was the biopharmaceutical company's top-selling drug for two decades, generating $21 billion of revenue in ...

US FDA approves Evolus' two new anti-wrinkle gels February 13, 2025 AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

AbbVie (NYSE: ABBV) recently released its Q4 results, with revenues and earnings comfortably above the street estimates. It reported sales of $15.1 billion and adjusted earnings of $2.16 per share ...

Carrie Strom, president of Global Allergan Aesthetics for AbbVie, said a new version of the Allē loyalty program was launched in October 2024 in an effort to benefit providers by increasing treatment ...